Category: ACN Newswire

香港, 2026年3月30日 - (亚太商讯 via SeaPRwire.com) - 专注于微创介入冷冻治疗领域的创新医疗器械平台企业——康沣生物科技（上海）股份有限公司（"康沣生物"或"公司"，股份代号：6922.HK）近日公布其截至2025年12月31日止年度的年度业绩。报告显示，公司商业化进程全面提速，核心财务指标表现卓越，全年收入实现跨越式增长，同时经营效益显著改善，亏损大幅收窄，展现出强大的成长动能与平台价值。营收高速增长，亏损大幅收窄，经营质量持续提升2025年，康沣生物实现收入人民币9526.8万元，较2024年同期的5353.1万元激增78.0%。年内亏损大幅收窄至人民币4445.6万元，较2024年同期的1.11亿元显著减少60.0%，展现出卓越的运营效率与成本控制能力。公司整体毛利达到人民币6398.4万元，同比增长66.6%。毛利率保持在67.2%的健康水平。报告期内，公司持续优化研发效率，研发开支同比减少58.6%至人民币3043.8万元，这主要得益于部分产品完成注册后相关投入减少，以及员工成本优化，反映了公司研发管线正从早期投入期向后期收获期稳步过渡。冷冻产品矩阵全面发力，呼吸介入成增长核心引擎业绩的强劲增长，主要得益于公司基于独特液氮冷冻消融技术和柔性导管技术平台打造的冷冻治疗产品线进入商业化放量阶段。其中，呼吸介入产品线表现尤为亮眼，成为驱动收入增长的绝对主力。2025年3月，公司的恶性狭窄冷冻消融系统获得中国国家药监局（NMPA）批准，并于同年5月成功商业化上市，销量迅速攀升。此外，此前已上市的冷冻粘连治疗系统销量亦持续增长。与此同时，公司与国际医疗巨头波士顿科学（波科）在中国市场的经销合作进一步深化，为公司贡献了可观的增量收入。更值得关注的是，公司的哮喘冷冻消融系统于2025年7月获得美国食品及药物管理局（FDA）授予的"突破性医疗器械"认证，标志着其创新技术获得国际权威认可，为未来进军全球市场奠定了坚实基础。成功完成新股配售，夯实资金基础助力全球拓展为支持未来研发及市场扩张，公司于2026年1月成功完成向特定投资者配售新H股。此次配售共发行5,595,000股H股，募集所得款项净额约为2973万港元。公司计划将募集资金主要用于血管介入、呼吸介入及肿瘤介入相关微创介入产品的研发、生产及商业化，以及为这些产品商业化的潜在海外业务扩张提供资金支持。此次融资不仅增强了公司的现金储备，为后续高价值在研产品（如肺周结节冷冻消融系统、慢阻肺冷冻喷雾治疗系统、哮喘冷冻消融系统及针对顽固性高血压的Cryofocus冷冻消融系统等）的临床开发和全球注册提供了坚实的资金保障，也彰显了专业投资机构对公司技术平台和长期发展前景的信心。展望未来：平台化优势凸显，迈向全球冷冻治疗领军者康沣生物凭借"一平台、多赛道"的独特商业模式，构建了涵盖血管介入、呼吸介入、肿瘤介入等多领域的强大产品管线。目前公司拥有总计25款产品组成的管线库，其中11款已实现商业化。随着更多产品陆续进入临床后期及报批阶段，公司平台价值有望持续释放。展望未来，康沣生物表示将继续执行清晰战略：迅速推动在研产品的临床开发和商业化；基于核心技术平台进一步扩大产品组合；持续投入底层技术研发；并选择性地拓展全球业务。公司正稳步从研发驱动向研发与商业化双轮驱动转型，朝着成为"全球微创介入冷冻治疗医疗器械平台"的愿景坚实迈进。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 29, 2026 - (ACN Newswire via SeaPRwire.com) - Condiments are an important carrier of Chinese culinary culture, playing an irreplaceable role in people’s daily diet, the upgrading of the catering industry, and the development of the food industry. As the absolute leader in the condiment industry, Foshan Haitian Flavouring & Food Co., Ltd. (A-share: 603288; H-share: 03288) delivered a high-quality performance report in 2025, leveraging its comprehensive product portfolio, leading digital and intelligent capabilities, and resolute internationalization strategy. The company continues to lead the industry and stands as a well-deserved industry benchmark.On 26th March, Haitian Flavouring released its 2025 annual report. Financial data shows that in 2025, the company achieved total revenue of RMB 28.873 billion, a year-on-year increase of 7.32%. Profitability improved simultaneously, with full-year net profit attributable to shareholders of the parent company reaching RMB 7.038 billion, up 10.95% year-on-year; net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses amounted to RMB 6.845 billion, a year-on-year rise of 12.81%, and the gross profit margin of its core condiment business reached 41.78%, representing a year-on-year increase of 3.15 percentage points. All operating data hit record highs, demonstrating strong development resilience and core competitiveness, and further widening the gap with industry peers.Product Matrix Diversification: Building a Foundation for Multi-Dimensional GrowthAs a time-honored Chinese enterprise with a 400-year history deeply rooted in the condiment industry, Haitian Flavouring has built a stable and resilient multi-dimensional growth pattern through its continuously enriched product portfolio for the mass market, with its core product categories maintaining a globally leading competitive position.In the soy sauce category, Haitian Flavouring has always adhered to a consumer-centric approach. Focusing on consumers’ diverse needs, the company has continuously innovated in flavor, functionality, and specifications, establishing a complete product matrix covering both basic mass consumption and various segmented scenarios. Its product lines include not only classic series, premium soy sauce series, and time-honored series for daily cooking, but also healthy and nutritious lines such as organic, less-sodium, iron-fortified, selenium-enriched, and gluten-free products, as well as trendy products such as matsutake premium soy sauce.In the oyster sauce category, the company insists on selecting premium whole oysters from high-standard marine ranches and simmering them into sauce. With genuine ingredients and rigorous craftsmanship, Haitian oyster sauce maintains its advantage of being “rich in flavor, free from any fishy taste; one simple step to seal in freshness” . Currently, the company has launched diversified products such as Haitian superior oyster sauce and golden label oyster sauce, covering different flavors, packaging specifications, and price points. In response to consumer demand, the company has carried out scenario-based innovation, successively launching new products such as spicy oyster sauce and matsutake fresh oyster sauce to continuously enrich consumer choices.In the seasoning sauce category, the company’s products are mainly divided into two categories: basic flavored sauces and compound flavored sauces. It has built a product system with rich categories, diverse flavors, and multiple scenarios, such as Chu Hou Paste, Hoisin Sauce, Sauce for Rice, and Mushroom Sauce, which are suitable for different cooking methods. Meanwhile, the company adheres to a dual-wheel layout of “traditional vinegar + specialty vinegar,” developing regional characteristic rice vinegar such as sweet rice vinegar, selected fresh rice vinegar, and kangle vinegar, as well as specialty fruit vinegar including sugar-free apple cider vinegar and raw orange vinegar. This has formed a rich and diverse vinegar product system, further consolidating the company’s all-category competitive advantages, providing solid support for its steady performance growth, and building a profound market barrier.Benefiting from the recovery of the consumer market and its extensive product portfolio, Haitian Flavouring’s core categories including soy sauce, oyster sauce, and seasoning sauces maintained steady development in 2025, achieving operating revenues of RMB 14.934 billion, RMB 4.868 billion, and RMB 2.917 billion respectively, with year-on-year growth rates of 8.55%, 5.48%, and 9.29%. The three major categories maintained positive growth simultaneously, providing solid support for the overall performance.As of the end of 2025, Haitian Flavouring has established 7 product series each generating over RMB 1 billion in revenue, and more than 30 product series each exceeding RMB 100 million, with product concentration and competitiveness continuing to improve. Among them, the two products series of Golden Label Light Soy Sauce and Mushroom Dark Soy Sauce have been bestsellers for over 60 years. The two products series of Premium Soy Sauce and Haitian Superior Oyster Sauce have achieved annual revenue of over RMB 1 billion per product for over 10 consecutive years, becoming the core drivers supporting the Company's steady performance growth and demonstrating strong product vitality and high market recognition.While consolidating its advantages in core product categories, Haitian Flavouring proactively adapts to the trend of consumption upgrading, invests heavily in new product development, creates trend-setting new products, and forms a continuously evolving growth flywheel. Supported by its industry-leading product strength, the nutritionally healthy product series, represented by organic and less-sodium options, achieved operating revenue with a year-on-year growth rate of 48.3%, significantly outperforming the industry average growth rate and opening up a new growth curve for the Company's performance growth.Furthermore, Haitian Flavouring is proactively transforming itself from a "condiments supplier" to a "comprehensive flavor solutions provider," accurately capturing the new market opportunities brought by the industrialization and chain-upgrading of the catering industry. As of the end of 2025, the Company has cumulatively provided one-stop commercial condiment solutions to catering chains, food enterprises, and numerous global retail brands, further expanding its profit margins.Meanwhile, the Company boasts leading digitalization-enabled flexible production and customized service capabilities. It can produce up to over 20 specifications and more than 130 SKUs of different products on the same production line, with its customized service response and time-to-market speed leading the industry. Powered by its digital transformation, the Company's ultimate supply chain has established a new paradigm for the collaborative development of "customization, scale, quality-to-price performance ratio" in the manufacturing industry. This not only ensures stable and safe product quality to meet the stringent requirements of chain catering but also caters to the diverse needs of different users for condiments.Digitalization Empowers Across the Entire Chain, Technological Innovation Boosts EfficiencyTechnology development and technological innovation are the core engines driving Haitian Flavouring's performance growth. The Company proactively embraces the AI era, deeply integrating artificial intelligence and big data into the entire chain of R&D, production, supply, and sales. This promotes the organic integration of cutting-edge digital technologies with millennia-old brewing techniques, achieving a comprehensive leap in production efficiency, product quality, and operational effectiveness.Every year, Haitian maintained R&D investment at approximately 3% of its operating revenue, solidifying the foundation for innovation with a long-term perspective. Meanwhile, the Company’s Gaoming production base was successfully recognized as the world's first "Lighthouse Factory" in the soy sauce brewing industry, a benchmark for smart manufacturing certified by the World Economic Forum, redefining the Digitalization height of the traditional condiments industry.With comprehensive digital empowerment, Haitian's supply chain operational efficiency has significantly improved. In 2025, the Company's On-Time In-Full (OTIF) delivery rate continued to optimize, and customer service levels reached a new height. At the same time, the ratios of manufacturing expenses and direct labor costs to operating costs-two core cost indicators- surpassed those of most peers, achieving a dual breakthrough in quality improvement, efficiency enhancement, and cost control.Thanks to its outstanding digital practices, in 2025, the Company won numerous awards, including the "CGF China Supply Chain Digitalization and Sustainable Resilience Development Case" and the "National Typical Cases of Digital Transformation in Manufacturing", establishing itself as a benchmark for digital transformation in the industry. Additionally, the national standard " General Technical Requirements for Food Production Digital Factories", led by Haitian, was officially released. This fills the gap in the field of digital factory construction in China's food industry and provides authoritative and unified technical guidelines and an implementation framework for the Digitalization upgrading of the food industry.Leveraging smart technologies, the Company also achieved notable progress in green manufacturing. In terms of energy structure, the scale of solar photovoltaic power stations increased by nearly 100%, and a biomass power generation project was also put into operation. Power generated from green energy reached 29 million kWh, while the share of green electricity exceeded 28%. Through a smart water-saving system, the Company made dedicated efforts to set a benchmark in water conservation, recycling 1.88 million cubic meters of water over the past year, equivalent to the capacity of 752 standard swimming pools. In 2025, the Company implemented 128 energy-saving and carbon-reduction initiatives, these efforts resulted in a total reduction of 29,000 tonnes of carbon dioxide equivalent, marking a solid step forward in its green and low-carbon development.Accelerating Global Expansion, Charting a New Course on the World StageWhile maintaining its leading position and deepening its presence in the domestic market, Haitian Flavouring has been proactively expanding its international footprint and accelerating its pace to "set sail" for global markets. Adhering to a dual-track development approach of "global standards + local adaptation," the Company’s products are now sold in over 80 countries and regions worldwide. It has been named a "Chinese Brand Loved by Foreigners" for two consecutive years, reflecting its growing international influence and marking a transition from "product export" to "enterprise globalization."Recently, the Company successfully upgraded its British Retail Consortium (BRC) rating from Grade B to Grade A, a testament to its quality control system receiving internationally recognized accreditation and achieving a world-class standard. This accomplishment has instilled strong confidence in the Company’s efforts to further expand its global footprint and enter premium retail channels in Europe and the United States, while also underscoring the high quality and international competitiveness of Haitian’s products.On March 17, the Company was recognized as a Leading Enterprise in the 2026 Forbes China Pioneer Innovators in Industry Development Selection in recognition of its digital and intelligent transformation as well as its green development practices, affirming the Company’s long-term value creation.In June 2025, the Company was successfully listed on the Hong Kong Stock Exchange, marking a new milestone as it now operates on the dual A+H share platform. The listing attracted eight prominent domestic and international institutions, including Hillhouse Capital and the Government of Singapore Investment Corp (GIC), to serve as cornerstone investors, underscoring the international market's recognition of the Company's growth potential and providing ample capital to support its global expansion strategy. In the same year, the Company also established its overseas production base, further enhancing its global production and sales network. This provides a solid foundation for building a global supply chain and leveraging the Company's competitive advantages from the domestic market, marking a critical step forward in the execution of its internationalization strategy.On the brand development front, the Company continues to deepen its commitment to “400-Year Legacy of Oriental Flavor” Through iconic IPs such as Chef of China, it has captured widespread attention across Mainland China, Hong Kong, Macao, Taiwan, and beyond, creating a deep resonance between traditional brewing culture and modern consumer experiences. In addition, the Company launched the “Ambassador for Chinese Flavor” Initiative, bringing together collaborators to ignite global enthusiasm for authentic Chinese cuisine.Overall, in 2025, Haitian Flavouring delivered an impressive performance, driven by its steady operations and forward-looking strategy. Building on a comprehensive product matrix and leveraging digital empowerment, the Company has successfully achieved a strategic transformation through in-depth, full-channel operations. This has enabled it to establish a core competitive edge capable of withstanding market volatility and navigating industry cycles.Looking ahead, the Company will continue to uphold its dedication to craftsmanship and innovation, further consolidate its leading position in the domestic market, and steadily accelerate its global expansion. By doing so, it aims to support the high-quality development of the traditional condiment industry, bring the taste of China to the world, and continue to lead the industry toward a new era of higher quality. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月28日 - (亚太商讯 via SeaPRwire.com) - 2026年3月27日，华商能源科技股份有限公司（"本公司"或"公司"，简称"华商能源"，股票代码：206.HK）董事会（"董事会"）公布了本公司及其附属公司（合称"本集团"）截至2025年12月31日止年度（"2025年度"或"报告期"）的经审核业绩。2025年是华商能源成立三十周年，是公司继续执行落实战略转型、卡位绿色能源新赛道、持续创新突破的战略转型之年。报告期内，公司秉持创新发展的工作总基调，持续优化业务结构，聚焦"技术研发和市场拓展"两大核心能力锻造，稳固传统领域优势的同时，整合资源，积极把握市场机遇，开拓新兴业务领域，实现了稳步发展。2025年本集团实现收入135.4 百万美元（相当于约人民币9.7亿元），在发展的转型期和新业务的培育期，连续3年把整体收入大致稳定在同一水平，整体业务规模具备较强发展韧性。战略转型持续推进，业务结构优化升级2025年是公司的战略转型之年。经过一年的战略调整，公司整体业务结构得到较大优化。报告期内，公司业务分部结构由上一年度的装备制造及总包、供应链及集成服务、资产管理及工程服务调整为当期的氢基能源、船海配套、智能电控、海事服务四个业务板块，体现了公司战略发展意图。公司产品矩阵条线清晰，重大业务取得关键进展报告期内，华商能源坚守"科技创新驱动绿色未来"核心理念，紧扣"中国领先的绿色能源与装备服务商"战略定位，持续深化"氢、船、智、海"业务布局。全年核心业务突破亮点鲜明：绿色能源板块聚焦氢、氨、醇三大技术赛道，绿色甲醇项目拿下全球首个ISCC Co-processing v2.0全流程认证，完成生物炭掺混制备工艺验证，顺利为招商轮船"港荣号"完成首单绿色甲醇加注；华商厦庚碱性电解槽成功出口印尼、意大利，2.2米幅宽碱性电解槽复合隔膜量产线投产，实现装备出海与核心材料自主可控双重突破；甲醇燃料供给系统在手订单13船套，跻身国内市场前列，同时前瞻布局海上浮式绿氨合成项目。船海装备配套板块抢抓行业绿色智能化机遇，翼型刚性风帆首台套交付测试，节油率优于预期，全年生效订单21台套；波浪补偿吊机斩获铺缆船、科考船首台套订单。海外市场依托香港全球服务中心，辐射欧洲、中东、亚太等区域，实现全球资源统筹与24小时快速响应，拓宽产品出海渠道。科技创新领域首次承担国家级重大科研任务，攻克深水主动波浪补偿吊机卡脖子难题，工业鸿蒙OS海洋装备智能控制系统、自主制氢电源等多项研发成果落地，筑牢核心技术壁垒。展望未来2025年是华商能源的战略重塑之年。以"船海为基、绿能为翼"的战略转型，是华商能源经过30 年发展后的再次出发，是在招商局集团的战略指引和产业赋能下，从传统海工装备制造商向"绿色能源与装备服务商"的全面升级。华商能源作为招商局集团重要战略布局的绿色能源上市平台，旗下招商局创新科技（香港）有限公司拟对华商能源增资，在战略上进一步夯实了华商能源的定位。展望未来我们于变局中明晰致远之径。我们将坚定公司发展战略，坚持公司科技属性，坚定"差异化"竞争策略，聚焦海洋场景，深耕"装备+能源+服务"的核心产业链条。一方面，持续推动船海装备基石业务向高端化、智能化、绿色化迭代；另一方面，全力打造绿色能源产业作为第二增长极，并积极培育智控科技这一未来创新引擎。我们将坚持"内生增长与收并购"双轮驱动，"场景驱动与产业协同"价值共创、国内国际双向循环的发展思路，系统构建"解决方案+生态协同"的统筹能力，从产品和能力上构建公司的核心护城河。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 28, 2026 - (ACN Newswire via SeaPRwire.com) - On 27 March, Ausnutria Dairy Corporation Ltd (Stock Code: 1717.HK, hereinafter referred to as "Ausnutria" or the "Company") officially released its 2025 annual results announcement. According to the announcement, Ausnutria achieved revenue of approximately RMB7.488 billion in 2025, representing a year-on-year increase of 1.2%. The Company recorded EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of approximately RMB518 million. Excluding the impact of one-off non-recurring items, core EBITDA reached approximately RMB616 million, demonstrating the Company's steady progress in navigating industry cycles. In 2025, driven by the dual engines of Family Nutrition and International Business, Ausnutria achieved resilient revenue growth while making significant breakthroughs in product category mix and regional market expansion. Notably, the international business of Kabrita has approached the RMB1 billion mark, with a compound annual growth rate exceeding 50% for three consecutive years, as its new global business ecosystem continues to take shape at an accelerated pace.Over the past year, the global economy has been marked by complexity and volatility, with heightened uncertainties arising from geopolitical tensions, inflation and exchange rate fluctuations. Compounded by intensifying competition amid a contracting domestic infant milk formula (IMF) market, the industry has faced multiple severe challenges. Against this backdrop, Ausnutria has maintained its strategic resolve, deepening its core strengths. The Company's international business has continued to unleash its growth momentum, while the Family Nutrition business has flourished across multiple fronts. Market share in core milk powder categories has steadily increased, and the level of refined management has improved significantly. Through these multi-dimensional efforts to enhance operational resilience, Ausnutria has laid a solid foundation for its long-term development.Kabrita International Business Approaches RMB1 Billion Mark with CAGR Exceeding 50% for Three Consecutive YearsIn 2025, Ausnutria further accelerated its internationalization efforts, continuously strengthening its comprehensive capabilities in global supply chain deployment, localised operations and digital collaboration, driving continued explosive growth in its overseas business. During the reporting period, revenue from the international business of Ausnutria's goat milk formula brand Kabrita recorded a year-on-year increase of 50.7% to approximately RMB974 million, making it the first infant goat milk formula brand from a Chinese dairy company to approach RMB1 billion in overseas sales. With a compound annual growth rate exceeding 50% for three consecutive years, the growing contribution of overseas markets has become increasingly prominent.Revenue from the Middle East market recorded a year-on-year increase of 65.5%, accounting for 45.7% of total overseas revenue and maintaining its position as Ausnutria's largest overseas sales market. Growth in this region was primarily driven by strong performance across established markets including Saudi Arabia, the UAE, Qatar and Kuwait, where the Company strengthened its promotion through medical and healthcare professional channels, continuously enhancing the medical endorsement of its goat milk formula products in these markets. Saudi Arabia delivered a particularly outstanding performance, leveraging deep collaborations with local maternity, infant care and medical institutions to effectively boost consumer acceptance and market penetration. Notably, Kabrita was awarded the "Fastest Growing Brand" accolade by Nahdi, the largest pharmacy retailer in the country. The newly entered Oman market in 2025 also exceeded expectations, injecting fresh momentum into the Company's growth.Revenue from the Commonwealth of Independent States (CIS) market recorded a year-on-year increase of 40.1%, accounting for 23.9% of total overseas revenue. As one of the Company's earliest overseas markets, the CIS market has achieved full product category coverage for Kabrita, encompassing infant formula, cereals, fruit purees, biscuits and more, comprehensively meeting the diverse consumer needs in the region. Through its "360° Omni-channel Marketing" strategy and "DTC Loyalty Program", the Company has engaged target consumers in a distinctive manner, building high value-added brand recognition and continuously consolidating and strengthening its core competitiveness in this market.Revenue from the North American market recorded a year-on-year increase of 39.5%, accounting for 22.2% of total overseas revenue. In 2025, Kabrita successfully entered Walmart, the largest retailer in the United States, and has now expanded into 780 stores, progressively developing both online and offline channels to reach a broader consumer base. In the newly entered Canadian market, the Company has been deepening its presence through the core Walmart channel while gradually building momentum on Amazon.In addition, the Company achieved 100% year-on-year growth in the Southeast Asian market by strengthening product differentiation through formula upgrades, with a particular focus on advancing digital community engagement and deepening collaboration with e-commerce channels and local platforms.Family Nutrition Achieves Steady Growth, Building Multi-dimensional Foundations for Future SuccessAs the Company's continuously nurtured "second growth curve" business, Ausnutria's nutrition products business achieved steady growth in 2025, with revenue recording a year-on-year increase of 5.2%. According to the announcement, this revenue growth was primarily attributable to continuous innovation in star probiotic strains and products, precise execution of channel strategies, and the sustained release of brand equity.Research-driven brand development. Ausnutria entered into a six-year strategic partnership with Jiangnan University, establishing the Joint Innovation Centre for Microecology and Functional Dairy as well as the Collaborative Innovation Centre for Probiotics, embarking on a new chapter of full-chain innovation collaboration. In the B2B segment, the Company achieved several key breakthroughs in probiotic strains: Bifidobacterium longum subsp. infantis YLGB-1496 was approved by the National Health Commission (NHC) for inclusion in the list of edible bacterial strains for infants and young children. With this approval, Ausnutria now possesses two nationally approved infant probiotic strains, earning its distinction as the "double champion" in China's infant probiotics field. Additionally, the independently developed Bifidobacterium animalis subsp. lactis CP-9 obtained the U.S. FDA GRAS (Generally Recognized as Safe) certification, marking Ausnutria's achievement of world-leading standards in research innovation and quality control. The continuous breakthroughs in strain technology provide strong and enduring core momentum for brand development. In the B2C segment in 2025, NC Stomach Care Powder and NC Nasal Comfort Probiotics maintained top rankings in category search popularity on Xiaohongshu. As certified by Euromonitor International, NC was awarded the title of "No.1 in National Sales of Australian Brand Nasal Sensitivity Probiotics".Innovation in response to emerging consumer demands. Bio(R) (Baoyichang(R)) Active Lactic Acid Bacteria Powder introduced a mini space capsule design, setting new aesthetic standards for probiotic products. Yili Changshi Probiotics, formulated with the patented BL-99 strain, achieved a top position on e-commerce bestseller lists. Diversified dosage form solutions, including instant-dissolve powder and micro-effervescent tablets, have effectively enhanced the product competitiveness of business partners. Throughout the year, NC launched 17 new products including G13 Growth Capsules and Sleep Well Probiotics, building a precision nutrition matrix covering gastrointestinal health, nasal sensitivity, sleep, growth, eye and brain health, liver and kidney health, and women's health.Channel upgrades fueling business development. The Company continued to deepen its presence in pharmaceutical channels, achieving simultaneous growth in both scale and pace of expansion. Collaboration with leading platforms was further strengthened, driving rapid growth in private domain e-commerce. The application of star probiotic strains was reinforced, enabling continued expansion of brand clientele. The Company also made breakthroughs in overseas market reach by expanding into European and North American markets. NC achieved steady growth on mainstream e-commerce platforms such as Tmall and JD.com, with the Stomach Care and Nasal Comfort product lines becoming leading brands in the cross-border health supplement category through channels such as Sam's Club and China Duty Free (CDF). The Company partnered with XKA and Fengxiangjia to develop its private domain presence, building an incremental online growth matrix. Offline, the Company consolidated its core client base, expanded into potential customer segments, and achieved initial results from pharmaceutical channel pilot programmes, laying a solid foundation for diversified business development.Domestic Milk Powder Business Steadily Increases Market Share, Solidifying Core FundamentalsChina's infant milk formula (IMF) industry is currently undergoing a period of deep structural adjustment, facing multiple pressures including overall market contraction, intensifying competition, and channel transformation, while birth rate fundamentals and channel structure remain under sustained pressure. During the reporting period, Ausnutria solidified its core fundamentals amid cyclical industry challenges, achieving steady growth in market share for its self-owned milk powder brands and recording overall revenue of approximately RMB5.321 billion.According to NielsenIQ and Syntun data, Kabrita's market share in China's all-channel Goat Milk formula market increased by 2.6 percentage points to 30.2% in 2025. NielsenIQ data further shows that Kabrita has maintained a market share of over 60% in China's imported infant and child goat milk formula market for eight consecutive years (2018–2025). Confirmed by Frost & Sullivan research, Kabrita continues to hold the undisputed position of "No.1 in Global Goat Milk Formula by Both Sales Volume and Sales Value", underscoring its unassailable market leadership.NielsenIQ data also indicates that the Company's cow milk formula business has stabilised its market share, marking the full conclusion of the transitional impact arising from earlier internal integration and channel restructuring. As of the date of this announcement, Ausnutria's Hyproca brand has been awarded dual certifications by iiMedia Research, namely "No.1 in National Sales of Comprehensive Nutrition Infant Formula in 2025" and "Pioneer of Comprehensive Nutrition Infant Formula in China", marking the third consecutive year that Hyproca has topped the comprehensive nutrition formula sales rankings.In 2025, the Company successfully completed the registration of 24 products across 8 series under the New National Standard 2.0 and launched 6 infant formula products across 2 series as well as 25 modulated milk powder products, offering consumers a wider range of functionalised and differentiated product choices. Kabrita was awarded the First Prize for Technological Advancement at the Science and Technology Awards for its research and development project titled "Research and Development of an Infant Formula that Supports Immune Regulation and Alleviates Immune Stress". Meanwhile, Hyproca 1897 was recognized as a "100% Quality Product", with the Company's product strength receiving authoritative endorsement.Lean Management Enhances Quality and Efficiency, Organizational Vitality Continues to FlourishIn 2025, Ausnutria continued to solidify the foundation for long-term development and achieve simultaneous improvements in organizational efficiency and development quality through a series of initiatives, including fully leveraging the momentum of its global supply chain, strengthening internal management effectiveness, establishing the cultural foundation for global collaboration, advancing the construction of its digital intelligence system, and enhancing its sustainable development governance capabilities.Global supply chain momentum unlocks new value growth opportunities. Following Ausnutria's acquisition of Amalthea Group, a Dutch goat cheese company, the Company achieved self-sufficiency in goat whey, a core ingredient for goat milk formula, while also adding cheese to its product portfolio. In 2025, the Company's Goat Cheese business recorded revenue of RMB1.006 billion, further deepening the moat of its internationalization strategy. Concurrently, the Company launched four major goat-based ingredients: goat cheese protein hydrolysate, hydrolyzed goat whey protein powder, goat lactoferrin, and goat colostrum powder. Several of these core goat milk ingredients achieved breakthroughs in commercially viable global applications from scratch, opening up new avenues for value creation for the Company.Internal management effectiveness strengthened to systematically drive sound operations. In 2025, the Company's inventory impairment provisions decreased by 0.9 percentage points year-on-year. Overall asset turnover ratio continued to improve, with inventory turnover days declining by 16 days. The Company continued to advance refined cost management, achieving a notable optimization in its expense ratio, which decreased by 1.4 percentage points year-on-year, with the selling and marketing expense ratio declining by 2.4 percentage points year-on-year.Global systematization of business philosophy to strengthen global strategic synergy. To better align with the pace of business development and reinforce Ausnutria's "one global chessboard" strategic approach, the Company officially released the "Ausnutria Business Philosophy (Overseas Edition)". Co-created through multiple rounds of in-depth discussions among over 60 core managers from Ausnutria's global operations, this business philosophy systematically establishes the core values and management principles for Ausnutria's overseas business. It serves as a tailor-made cultural compass and behavioral benchmark for overseas teams, laying a solid ideological foundation for future business development.Full-chain digital intelligence upgrade, empowering both business and management. The Company has introduced digital intelligence across all stages, from demand research and process design to implementation and execution, enabling traceable decision-making, monitorable processes and quantifiable results. Through the establishment of a data middle platform, intelligent analytical models and other tools, data has become the core enabler for optimising management and supporting business operations, fundamentally safeguarding the sustained and healthy development of the business.Upholding sustainable development principles and actively fulfilling corporate social responsibility. The Company has always adhered to a long-term vision for sustainable development, actively responding to the United Nations Sustainable Development Goals. Centred on three strategic pillars "Better Life, Better Nutrition, Better Environment” the Company has embedded sustainability principles into its operational management framework and across all stages of the value chain. In 2025, Ausnutria organized the "Hyproca Gesang Flower Charity Campaign" for the ninth consecutive year and launched the "Kabrita Care · Worry-free Pregnancy" maternal mental health charity initiative, among other activities. The Company has continued to contribute its corporate strengths in areas such as rural revitalization, education support, national nutrition enhancement and natural disaster relief.In 2025, with the support of consumers, shareholders and all sectors of society worldwide, together with the dedicated efforts of all employees, the Company successfully navigated the multiple challenges arising from economic and industry cyclical adjustments. Looking ahead to 2026, the internal and external environment remains complex and challenging. Ausnutria will continue to put consumers at the center, stay anchored to its operational objectives, accelerate systematic organizational development, drive growth through innovation, enhance efficiency through management excellence, and deliver superior products and performance to reward the trust of all stakeholders, in pursuit of long-term sustainable and high-quality development. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月28日 - (亚太商讯 via SeaPRwire.com) - 3月27日，澳优乳业股份有限公司（股份代号：1717.HK，以下简称"澳优"或"公司"）正式发布2025全年业绩公告。公告显示：2025年，澳优实现营业收入约人民币74.88亿元，同比增长1.2%；实现EBITDA（息税折旧及摊销前利润）约人民币5.18亿元；剔除一次性非经常性项目的影响，实现核心EBITDA约人民币6.16亿元，以稳健的步伐穿越行业周期。2025年，澳优通过全家营养与国际业务的双轮驱动，实现营收韧性增长，并在品类结构与区域市场拓展上取得突破。其中，佳贝艾特国际业务规模已接近10亿元，连续三年复合增长率超过50%，全球业务新生态正加速成型。过去一年，全球经济复杂多变，地缘政治、通胀及汇率波动等不确定性加剧，叠加国内婴配粉市场减量竞争日趋激烈，行业面临多重严峻挑战。在此背景下，澳优始终保持战略定力，深耕核心优势，国际业务势能持续释放，全家营养业务多点开花，奶粉核心品类市占率稳步提升，精细化管理水平显著提高，从多维度提升经营韧性，筑牢公司长远发展根基。佳贝艾特国际业务接近10亿规模，连续三年复合增长率超50%2025年，澳优进一步加快国际化步伐，不断增强全球供应链布局、本地化运营、数字化协同等综合硬实力，驱动海外业务继续取得爆发式增长。公告期内，澳优羊奶粉佳贝艾特（Kabrita）国际业务收入实现同比增长50.7%至约人民币9.74亿元，成为中国乳企第一个在海外市场销售额接近10亿规模的婴配羊奶粉品牌，连续三年复合增长率超50%，海外市场的增长贡献持续凸显。中东市场营收同比增长65.5%，占海外总营收45.7%，保持澳优海外最大销售市场的地位。该区域增长主要得益于沙特、阿联酋、卡塔尔、科威特等成熟市场全面开花，通过强化医疗专业渠道推广，持续提升公司羊奶粉在这些市场的医学认可度。其中沙特市场表现亮眼，依托与当地母婴及医疗机构的深度合作，有效提升消费者接受度与市场渗透率，并斩获当地最大的药房零售商Nahdi"增长最快品牌" 荣誉。2025年新开拓的阿曼市场表现超预期，为增长注入新动能。独联体市场营收同比增长40.1%，占海外总营收23.9%。作为公司首批布局的海外市场，独联体市场已实现佳贝艾特全品类覆盖，包含婴幼儿配方奶粉、谷物、果泥、饼干等，充分满足当地多元消费需求。通过"360°全域营销"与"DTC忠诚计划"以独特方式触达目标人群，构建高附加值品牌认知，实现公司在该市场的核心竞争力持续巩固与提升。北美市场营收同比增长39.5%，占海外总营收22.2%。2025年，佳贝艾特成功进驻美国最大零售商沃尔玛，目前已进入780家门店，有序拓展线上及线下渠道，覆盖更广泛消费群体。新进入的加拿大市场，深耕核心沃尔玛渠道，并在亚马逊渐进发力。此外，公司在东南亚市场通过配方升级以强化产品差异化，重点推进数字化社群运营，深化电商渠道与本地平台合作，实现了100%增长。全家营养稳步增长，多维筑基蓄力远航作为持续培育的"第二增长曲线"业务，2025年澳优营养品业务稳步增长，录得收入同比增长5.2%。公告显示，收入的增长主要得益于明星菌株和产品的不断创新、渠道策略的精准实施以及品牌效应的持续释放。科研驱动品牌发展。澳优与江南大学签订六年战略合作，成立微生态及功能乳联合创新中心和益生菌协同创新中心，开启全链路创新协同新征程。To B 业务板块，公司在菌株上实现多项关键突破：长双歧杆菌婴儿亚种 YLGB-1496 获国家卫健委批准列入婴幼儿可食用菌种名单，至此澳优已拥有两株国家批准的婴幼儿益生菌菌株，成为中国婴幼儿益生菌领域的"双冠王"；自主研发的动物双歧杆菌乳亚种 CP-9 通过美国 FDA GRAS 认证，标志着澳优在科研创新和质量管控方面达到世界领先水平。菌株技术的持续突破，为品牌发展提供强劲持久的核心动能。2025年，To C业务板块，NC养胃粉、舒鼻益生菌稳居小红书品类搜索热度前列；经欧睿国际认证，NC荣获 "澳洲品牌鼻敏益生菌全国销量第一"。创新响应新消费需求。葆益常(R)活性乳酸菌粉以迷你太空舱设计解锁益生菌产品颜值新高度；添加BL-99 专利菌株的伊利畅适益生菌跻身电商热销榜；闪溶粉、微泡片等多元剂型方案，有效提升合作伙伴产品竞争力。NC全年推出G13成长胶囊、恬睡益生菌等17款新品，构建起覆盖肠胃、鼻敏、睡眠、身高、眼脑、肝肾及女性健康等领域的精准营养矩阵。渠道升级助力业务发展。公司持续深耕药线渠道，规模与增速同步提升；深化头部平台合作，私域电商高速增长；强化明星菌株应用，品牌客户持续拓展；开拓欧美市场，海外市场空间实现突破。NC在天猫、京东等主流电商稳健增长，养胃、舒鼻系列产品在山姆、中免等渠道成为跨境保健品类目领先品牌；携手XKA、蜂享家布局私域，构建线上增量矩阵；线下稳固核心客户、拓展潜力客群，药线试点初见成效，为业务多元发展夯实基础。国内奶粉业务市占率稳步提升，筑牢核心基本盘当前中国婴配粉行业处于深度调整期，面临总量收缩、竞争加剧、渠道变革等多重压力，新生人口基本面与渠道结构持续承压。公告期内，澳优在行业周期性挑战中筑牢核心基本盘，实现自有品牌奶粉业务市占率稳步提升，录得整体收入约人民币53.21亿元。据尼尔森IQ及星图数据，2025年佳贝艾特在中国全渠道羊奶粉市场份额提升2.6个百分点至30.2%。尼尔森IQ数据显示，佳贝艾特已连续8年（2018年-2025年）在中国进口婴幼童羊奶粉市场份额超六成，并经过弗若斯特沙利文研究确认持续稳居"羊奶粉全球销量与销售额第一"，彰显其不可撼动的领头羊地位。尼尔森IQ数据同时显示，公司牛奶粉业务稳住市场份额，标志着因前期内部整合与渠道调整带来的阶段性影响全面结束。截至公告发布期，澳优旗下海普诺凯斩获艾媒咨询（iiMedia Research）"2025婴幼儿全面营养奶粉全国销量第一"及"中国全面营养婴配奶粉开创者"双重认证，这也是其连续三年蝉联全面营养奶粉销量榜首。2025年，公司顺利推进8个系列24款产品新国标2.0注册，完成2个系列6款婴幼儿配方奶粉、25款调制乳粉开发上市，为消费者提供更多功能化、细分化的产品新选择。佳贝艾特凭借《一种有助于免疫调节和缓解免疫应激的婴幼儿配方奶粉的研究与开发》荣获"科学技术奖技术进步奖"一等奖，海普诺凯1897获评"质量百分百产品"，产品力获权威认可。精益管理提质增效，组织活力持续迸发2025 年，澳优通过充分释放全球供应链势能、强化内部管理效能、塑造全球协同文化根基、推进数智化体系建设、提升可持续发展治理能力等举措，持续夯实长远发展基础，不断实现组织效率与发展质量的同步提升。全球供应链势能释放，开辟价值增长空间。澳优收购荷兰羊奶酪公司Amalthea Group后，实现核心羊奶粉原料——羊乳清自给自足，并新增奶酪品类。2025年，公司羊奶酪业务录得收入10.06亿元，进一步挖深国际化战略护城河。与此同时，公司推出羊奶酪蛋白酶解物、水解羊乳清蛋白粉、羊乳铁蛋白以及羊初乳粉四大羊原料，其中多款核心羊乳原料实现了全球可商业化应用从无到有的突破，为公司开辟全新的价值增长空间。内部管理效能强化，系统推进稳健经营。2025年，公司存货减值准备同比减少0.9个百分点；整体资产周转率持续优化改善，存货周转天数下降16天。公司持续推进费用精细化管控，费用率实现显著优化，同比下降1.4个百分点，其中营销费用率同比下降2.4个百分点经营理念全球体系化构建，加强全球战略协同。为更好地匹配业务发展步伐，强化澳优"全球一盘棋"的战略协同，澳优正式发布《澳优经营理念（海外版）》。该经营理念由澳优全球60余位核心管理者通过多轮深度研讨共创而成，系统构建了澳优海外业务的核心价值与管理原则，为海外团队量身打造了文化罗盘与行为基准，为未来业务发展奠定了坚实的思想根基。全链路数智化升级，为业务与管理双向赋能。公司从需求调研、流程设计到落地执行的全环节引入数智化，实现决策可追溯、过程可监控、结果可量化；通过搭建数据中台、智能分析模型等工具，让数据成为优化管理、支撑业务的核心抓手，从根本上保障业务的持续健康发展。秉持可持续发展理念，积极践行企业社会责任。公司始终秉持可持续发展的长期愿景，积极响应联合国可持续发展目标，围绕"更优生活、更优营养、更优环境"三大战略支点，将可持续发展理念融入运营管理体系及价值链各环节。2025年，澳优连续第九年开展"海普诺凯格桑花公益行"、启动"佳贝爱・孕无忧"孕产妇心理健康公益行等活动，持续在乡村振兴、兴教助学、国民营养提升、自然灾害救助等方面持续贡献企业力量。2025年，依托全球消费者、股东、社会各界的支持及全体员工的奋力拼搏，公司成功抵御经济及行业周期性调整带来的多重挑战。展望 2026年，内外部环境依然复杂严峻，澳优将继续以消费者为中心，锚定经营目标，加快体系化建设，以创新驱动发展，以管理提升效能，以更优质的产品与业绩回馈各方信赖，实现长期可持续高质量发展。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com